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Abstract 
Chronic mucocutaneous candidiasis (CMC) is a group of heterogeneous disorders 
characterised by primary selective susceptibility to chronic, recurrent Candida infections. 
The genetic defect of one subgroup of CMC patients have been identified as mutations of 
the autoimmune regulator (AIRE) gene. Recent data implicated the AIRE gene in iNKT 
cell development, raising the possibility that iNKT cells may be important in defending 
against Candida infections. In this study, we enumerated the circulating iNKT frequency 
in 22 CMC patients (9 with AIRE gene mutations) and 25 healthy controls. We also 
examined the effect of Candida stimulation on iNKT cells in vitro. Our data 
demonstrated that peripheral iNKT cell frequency is significantly reduced in CMC 
patients compared to healthy controls, regardless of their AIRE gene mutation status. 
Direct stimulation with Candida did not induce iNKT cell proliferation. Furthermore, 
circulating iNKT cell frequencies in some healthy controls were comparable to CMC 
patients. These observations suggest that iNKT cell deficiency is part of the CMC disease 
phenotype irrespective of molecular aetiologyAIRE gene mutations but does not appear to 
confer susceptibility to chronic Candida infections. We postulate that the reduced 
circulating iNKT cell frequency in CMC is a consequence rather than a cause of chronic 
Candida infections.  
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Invariant natural killer T (iNKT) cells are a unique subset of T cells which use a 
restricted repertoire of T cell receptor α- and β-chains (Vα24-Jα281 preferentially paired 
with Vβ11 in humans) and express surface molecules that are usually found on natural 
killer cells. Unlike conventional T cells, iNKT cells recognise glycolipids presented by 
major histocompatibility complex class I-like molecules, CD1d. Data from rodent models 
implicate iNKT cells in the regulation of many immune responses [1] but their role in 
human diseases remains to be fully defined. Chronic mucocutaneous candidiasis (CMC) 
is a rare, heterogeneous group of conditions characterised by a primary selective 
susceptibility to persistent or recurring Candida infections [2]. A subset of CMC patients 
harbour mutations of the autoimmune regulator (AIRE) gene and also develop organ-
specific autoimmune diseases and ectodermal dystrophy [3], hence termed Autoimmune 
Poly-Endocrinopathy Candidiasis Ectodermal Dystrophy (APECED) syndrome. 
Interestingly, Lindh et al recently reported that iNKT cell development was impaired in 
aire-/- mice and in 3 individuals with AIRE gene mutations [4]. In contrast, Pitt and 
colleagues showed that iNKT cell development is unimpaired in aire-/- mice [5] and 
Somech et al reported that children with Omenn syndrome have reduced transcriptional 
expression of the AIRE gene but normal iNKT cell frequency [6]. The reason for the 
discrepant findings is not clear. Furthermore, peripheral iNKT cell frequency in CMC 
patients without AIRE gene mutations has not been studied.  
 
We enumerated the circulating iNKT cell frequency in 22 CMC patients including 9 with 
AIRE gene mutations, and 25 healthy controls (Table 1). The two groups were similar in 
age and gender. None of the CMC patients were taking immuno-modulatory medications 
at the time of study. iNKT cells were defined by the co-expression of Vα24 and Vβ11 on 
CD3+ lymphocytes using flow cytometry (gating strategy is shown in supplementary 
figure 1). This method has been demonstrated to correspond well with iNKT cell 
frequency determined by CD1d tetramers or a monoclonal antibody specific for the 
invariant CDR3 loop of the human canonical Vα24Jα18 chain, even at low numbers [7,8]. 
The frequency of circulating iNKT cells among CD3+ lymphocytes in CMC patients was 
significantly lower compared to healthy controls (mean=0.018±0.003% versus 
0.061±0.012%,  p=0.008) regardless of the AIRE gene mutation status (Fig. 1a&b), 
indicating that reduced iNKT cell frequency is part of the CMC disease phenotype 
irrespective of molecular aetiology. Serial measurements over a period of 6-12 months in 
5 healthy volunteers and 3 CMC patients (Fig. 1c&d) showed that the iNKT cell 
frequency was stable over time. The absolute number of circulating iNKT cells was not 
specifically determined but since observations from routine clinical practice suggest that 
the lymphocyte counts of all CMC patients were usually within normal ranges, we 
anticipated that the absolute numbers of peripheral blood iNKT cells among CMC 
patients were also reduced compared to healthy controls. Consistently, we have estimated 
the absolute circulating iNKT cell numbers based on the contemporaneous absolute 
lymphocyte counts of CMC patients and mean reference lymphocyte counts of healthy 
volunteers, and showed that the absolute numbers of peripheral blood iNKT cells were 
also significant lower among CMC patients than healthy controls (supplementary figure 3 
& supplementary tables 1&2). 
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In this study, although the range of iNKT cell frequency among healthy individuals is 
wide, it is evident that the iNKT cell frequency was comparable between some healthy 
individuals and CMC patients suggesting that reduced circulating iNKT cell frequency 
per se does not is perhaps unlikely to confer susceptibility to Candida infections. 
 
To further investigate whether iNKT cells may play a role in the protection against 
Candida infections, we stimulated control PBMC with total Candida extract and 
determined whether this induced iNKT cell expansion. As anticipated, stimulation of 
PBMC with an iNKT cell-specific agonist, α-galactosylceramide, induced marked 
expansion of iNKT cells after 10-12 days. In contrast, no apparent expansion of iNKT 
cells was observed in Candida-stimulated PBMC culture (Fig. 2a). In addition, co-culture 
of iNKT cell lines generated from 2 healthy individuals with total Candida extract in the 
presence of irradiated autologous PBMC also did not induce proliferation (Fig. 2b).  
 
Taken together, these observations argue against a significant key role of for iNKT cells 
in the protection against Candida, but raise the possibility that circulating iNKT cell 
deficiency in CMC patients is a direct or indirect consequence of persistent Candida 
infections. However, further experiments are needed to address this possibility. 
Consistent with this hypothesis, circulating iNKT cell frequency rises with age in healthy 
controls but not among CMC patients within our cohort but our sample sizes are small 
(supplementary figure 2). This hypothesis may also account for the contradictory findings 
of iNKT cell development in aire-/- mice since the frequency of iNKT cells could be 
affected by their previous exposure to Candida infections. It would be interesting to 
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monitor the circulating iNKT cell frequency in aire-/- and wild-type mice following 
repeated Candida infections and collect longitudinal data on iNKT cell frequency of 
healthy and CMC children. 
 
In this study, iNKT cell frequency in the infected sites was not determined as no biopsy 
sample was available. This is because for CMC patients, Candida infections are usually 
localised to the gut and skin, and diagnosis is confirmed by culture so that biopsies of the 
infected sites are not indicated. Therefore, peripheral iNKT cell deficiency could be a 
consequence of preferential recruitment of iNKT cells to the sites of infection. However, 
we consider this a less attractive explanation because iNKT cells do not respond directly 
to Candida stimulation although an indirect role for iNKT cells in the defence against 
Candida remains possible. Furthermore, it does not adequately account for the 
observations that peripheral iNKT cell frequency of some healthy individuals is 
comparable to that of CMC patients. Determination of the activation states of the iNKT 
cells may be helpful in addressing these possibilities but requires a dedicated study in the 
future.  
 
It has been suggested that different iNKT cell subsets with differential ability to skew 
cytokine production is a key mechanism by which iNKT cells regulate immune responses 
[9-11]. In this study, the frequencies of different iNKT cell subsets were not determined 
as we were limited by the amount of peripheral blood samples available, especially those 
from children. Further study dedicated to the study iNKT cell subsets and cytokine 
profiles in CMC patients are warranted. 
  
To conclude, our data suggest that iNKT cell deficiency is part of the CMC disease 
phenotype irrespective of molecular aetiologyAIRE gene mutations but does not appear to 
confer susceptibilityand whether it is a cause or consequence to of chronic Candida 
infections remains to be determined. 
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Figure Legends 
 
Figure 1. Circulating iNKT cell frequency of CMC patients is significantly reduced 
compared to healthy controls and is independent of the AIRE gene mutation status. The 
frequency of peripheral blood iNKT cells was enumerated using flow cytometry. iNKT 
cells were identified by the co-expression of CD3+Vα14+Vβ11+ cells. (a) The percentage 
of iNKT cells among lymphocytes was shown for all CMC patients (CMC, filled squares) 
and healthy controls (Controls, filled triangles). (b) The percentage of iNKT cells among 
lymphocytes was shown for CMC patients with AIRE gene mutation (AIRE-/-, filled 
squares), without AIRE gene mutation (AIRE+/+, unfilled squares) and healthy controls 
(Controls, filled triangles). Horizontal lines represent median values of the groups. (c&d) 
Peripheral blood iNKT cell frequency is stable over time. Circulating iNKT cell 
frequency was measured over a period of 6 to 12 months in 5 healthy volunteers (c) and 3 
CMC patients (d).  
 
Figure 2. iNKT cells do not proliferate in response to Candida stimulation. (a) 2x106 
PBMC from 3 healthy controls were stimulated total Candida extract (1.1 µg/ml protein 
or 1.1x105 CFU/ml) or α-GC (100 ng/ml)  for 12 days, the percentages of iNKT cells 
among lymphocytes were enumerated as earlier described at day 3, 5, 7, 10 and 12. A 
representative figure is shown. (b) An iNKT cell line, generated by 5 repeated stimulation 
with α-GC every 10-14 days, from a healthy individual was labelled with 
carboxyfluorescein succinimidyl ester (CFSE) and stimulated with total extracts of 
Candida or α-GC (100 ng/ml) in the presence of irradiated autologous PBMC for 12 
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days. Dilution of CFSE signals among 6B11+ lymphocytes (which specifically identifies 
iNKT cells) were measured using flow cytometry. Similar findings were obtained with 
another iNKT cell line from a different individual. 
 
Supplementary figure legends 
 
Supplementary figure 1. (a) The gating strategy and representative flow cytometric plots 
of iNKT cell frequency enumeration. PBMC were stained with flurochrome-conjugated 
anti-CD3, anti-Vα14 and anti-Vβ11. The lymphocyte gate was set based on forward and 
side scattered characteristics. A minimum of 500,000 lymphocyte-gated events were 
collected for each sample. The number of CD3+Vα14+Vβ11+ cells was expressed as a 
percentage of CD3+ lymphocytes. Representative flow-cytometric plot of a healthy 
individual (left panel) and a CMC patient (right panel) together with the gating strategy 
are shown.  
 
Supplementary figure 2. Circulating iNKT cell frequencies of iNKT cells increase with 
age in healthy individuals but not in CMC patients regardless of their AIRE gene 
mutation status. (a-b) The percentages of peripheral iNKT cells of healthy individuals (a) 
and CMC patients (b) were plotted against their ages. Correlation between iNKT cell 
frequency and age was analyzed using Pearson’s correlation. The solid line and the dotted 
lines represent linear relationship and the 95% confidence intervals. (c) The percentages 
of lymphocytes of CMC patients were classified according to their age and AIRE gene 
mutation status: CMC patients with AIRE gene mutations who are adults (age>16 years, 
adult AIRE-/-) or children (age≤16 years, Child AIRE-/-), CMC patients without AIRE gene 
mutations who are adults (age>16 years, adult AIRE+/+) or children (age≤16 years, Child 
AIRE+/+). Horizontal lines represent median values of the groups. 
 
Supplementary figure 3. Estimated circulating iNKT cell numbers are reduced in CMC 
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patients. The absolute numbers of peripheral blood iNKT cells were calculated by 
multiplying the following formula: {[% of iNKT cells (of lymphocytes)] x [Lymphocyte 
counts from contemporaneous complete blood counts (No. of cells/ml of blood)]}. Since 
contemperanous complete blood counts were not performed in healthy volunteers and 8 
CMC patients, for these subjects, the mean laboratory reference values of lymphocyte 
counts for healthy individuals (Comans-Bitter WM et al, 2006 (ISBN-10 90-73436-75-3)) 
were used instead of the measured lymphocyte counts. The estimated iNKT cell numbers 
of healthy volunteers were compared (Mann Whitney) with those of CMC patients, either 
for those with measured lymphocyte counts, or for the entire patient group.  
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